These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
224 related articles for article (PubMed ID: 12471829)
41. [Humoral mechanisms in the pathogenesis of arterial hypertension with emphasis on the renin-angiotensin-aldosterone system and natriuretic substances]. Horký K Vnitr Lek; 1989 Mar; 35(3):219-25. PubMed ID: 2525299 [TBL] [Abstract][Full Text] [Related]
43. New insights into the cardiac natriuretic peptides. Bonow RO Circulation; 1996 Jun; 93(11):1946-50. PubMed ID: 8640966 [No Abstract] [Full Text] [Related]
44. Atrial natriuretic hormone: a regulator of blood pressure and volume homeostasis. Laragh JH; Atlas SA Kidney Int Suppl; 1988 Sep; 25():S64-71. PubMed ID: 2972865 [TBL] [Abstract][Full Text] [Related]
45. The effect of ACE inhibitors and atrial natriuretic factor on the cardiorenal axis in man. Struthers AD Br J Clin Pharmacol; 1992 Jul; 34(1):21-4. PubMed ID: 1385970 [No Abstract] [Full Text] [Related]
46. Natriuretic peptides and their therapeutic potential. Cho Y; Somer BG; Amatya A Heart Dis; 1999; 1(5):305-28. PubMed ID: 11720638 [TBL] [Abstract][Full Text] [Related]
47. Effects of naturally acquired decompensated mitral valve regurgitation on the renin-angiotensin-aldosterone system and atrial natriuretic peptide concentration in dogs. Häggström J; Hansson K; Kvart C; Karlberg BE; Vuolteenaho O; Olsson K Am J Vet Res; 1997 Jan; 58(1):77-82. PubMed ID: 8989501 [TBL] [Abstract][Full Text] [Related]
48. Recommendations for the clinical use of cardiac natriuretic peptides. Emdin M; Clerico A; Clemenza F; Galvani M; Latini R; Masson S; Mulè P; Panteghini M; Valle R; Zaninotto M; Ganau A; Mariotti R; Volpe M; Aspromonte N; Cacciatore G; Cappelletti P; L'Abbate A; Miglio F; Ottani F; Pagani F; Passino C; Plebani M; Sarzani R; Zucchelli G; ; ; ; ; ; Ital Heart J; 2005 May; 6(5):430-46. PubMed ID: 15934421 [No Abstract] [Full Text] [Related]
50. [Significance of the system of atrial natriuretic peptides in heart failure and hypertension]. Gurevich MA; Mravian SR; Veselova TE Kardiologiia; 2003; 43(9):81-6. PubMed ID: 14593373 [TBL] [Abstract][Full Text] [Related]
51. [Erythrocyte cation transport in arterial hypertension: interrelation with the renin-angiotensin-aldosterone system and the atrial natriuretic factor]. Manunta P; Melis MG; Soro A; Pazzola A; Troffa C; Motzo S; Pala F; Madeddu P; Tonolo G; Glorioso N Boll Soc Ital Biol Sper; 1989 Nov; 65(11):1009-16. PubMed ID: 2560922 [TBL] [Abstract][Full Text] [Related]
52. [Plasma atrial natriuretic peptide, renin-angiotensin-aldosterone system in patients with cardiac failure]. Wang B Zhonghua Xin Xue Guan Bing Za Zhi; 1991 Aug; 19(4):251-2. PubMed ID: 1839893 [No Abstract] [Full Text] [Related]
54. [Natriuretic hormone and blood pressure in patients with arterial hypertension]. Tomashets EA; Mazur NA; Masenko VP Kardiologiia; 1992 Jan; 32(1):60-3. PubMed ID: 1535395 [TBL] [Abstract][Full Text] [Related]
55. Effects of pharmacological modulation of the renin-angiotensin-aldosterone system on salt sensitivity in patients with borderline hypertension. Borghi C; Boschi S; Costa FV; Bacchelli S; Degli Esposti D; Piccoli M; Ambrosioni E J Hypertens Suppl; 1993 Dec; 11(5):S248-9. PubMed ID: 8158368 [No Abstract] [Full Text] [Related]
56. [Natriuretic hormones (atrial and digitalis-like) in patients with arterial hypertension during exercise]. Almazov VA; Khirmanov VN; Shcherbak AI; Krutikov AN; Danil'chenko AR; Kireenkov IS Kardiologiia; 1992 Jan; 32(1):56-60. PubMed ID: 1535394 [TBL] [Abstract][Full Text] [Related]